Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

LifeStance Health Group, Inc. LFST

Set alert

Price alert · LFST

All alert types
13.26 USD -0.14 -1.04%

At close · Nov 2

13.50 +0.24 +1.81%

After hours · Nov 2, 7:52 PM ET

Bid
13.26 × 2
Ask
13.27 × 2
13.18 Day range 13.60
4.77 52-week range 13.76
YTD
+88.35%
1 year
+170.61%
Open
13.50
Prev close
13.40
Mkt cap
5.04B
Vol
3.36M
Avg vol
4.40M
EPS
0.13
P/E
102.00
Div yield
0.00%
More statistics
Low
13.18
High
13.60
Forward P/E
30.78
Beta
1.30
Short ratio
2.99
Inst. own
89.69%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
12.48
200-d avg
9.34
1y target
14.45

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Aug 6, 2026Earnings: 0.06; estimate 0.03275; surprise 83.21%
  • Aug 7, 2026Rating: BTIG · Buy → Buy
  • Aug 14, 2026Rating: JP Morgan · Neutral → Neutral
  • Aug 19, 2026Rating: BTIG · Buy → Buy
  • Sep 9, 2026Rating: Canaccord Genuity · Buy → Buy
  • Sep 10, 2026Rating: Barclays · Overweight → Overweight
  • Oct 5, 2026Rating: Keybanc · Overweight → Overweight
Signals (24)
NameDateAgo
RSI: OverboughtOct 29, 20264 days ago
SMA: BullishOct 22, 20261 week ago
MACD: Buy SignalOct 22, 20261 week ago
SMA: BullishOct 21, 20261 week ago
SMA: BearishOct 16, 20262 weeks ago
MACD: Sell SignalOct 16, 20262 weeks ago
SMA: BearishOct 15, 20262 weeks ago
SMA: BullishOct 14, 20262 weeks ago
SMA: BearishOct 13, 20262 weeks ago
SMA: BullishOct 12, 20263 weeks ago
MACD: Buy SignalOct 12, 20263 weeks ago
SMA: BullishOct 9, 20263 weeks ago
SMA: BearishOct 8, 20263 weeks ago
SMA: BullishOct 5, 20264 weeks ago
SMA: BearishOct 1, 20261 month ago
SMA: BullishSep 30, 20261 month ago
SMA: BearishSep 24, 20261 month ago
SMA: BearishSep 22, 20261 month ago
MACD: Sell SignalSep 15, 20261 month ago
MACD: Buy SignalSep 14, 20261 month ago
MACD: Sell SignalAug 26, 20262 months ago
RSI: OverboughtAug 19, 20262 months ago
MACD: Buy SignalAug 11, 20262 months ago
SMA: BullishAug 10, 20262 months ago

Financial health

Altman Z-Score

4.73 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

8 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-3 / 5 overall

  • DCF 3
  • Return on Equity 2
  • Return on Assets 3
  • Debt / Equity 3
  • P/E 1
  • P/B 3

Valuation

P/E 235×
FY 2019: -137×FY 2020: -26.4×FY 2021: -9.1×FY 2022: -8.1×FY 2023: -15.4×FY 2024: -49.1×FY 2025: 235×
FY 2019 5y median -9.1× FY 2025
P/S 1.9×
FY 2019: 38.5×FY 2020: 21.7×FY 2021: 4.7×FY 2022: 2.0×FY 2023: 2.7×FY 2024: 2.2×FY 2025: 1.9×
FY 2019 5y median 2.2× FY 2025
P/B 1.8×
FY 2019: -49.2×FY 2020: 8.2×FY 2021: 2.0×FY 2022: 1.2×FY 2023: 2.0×FY 2024: 1.9×FY 2025: 1.8×
FY 2019 5y median 1.9× FY 2025
P/FCF 24.7×
FY 2019: 2993×FY 2020: -176×FY 2021: -36.7×FY 2022: -66.3×FY 2023: -50.1×FY 2024: 32.6×FY 2025: 24.7×
FY 2019 5y median -36.7× FY 2025
EV/EBITDA 33.8×
FY 2019: 426×FY 2020: 973×FY 2021: -13.0×FY 2022: -14.8×FY 2023: -31.5×FY 2024: 78.4×FY 2025: 33.8×
FY 2019 5y median -13.0× FY 2025
EV/Sales 1.9×
FY 2019: 38.9×FY 2020: 22.6×FY 2021: 4.7×FY 2022: 2.5×FY 2023: 3.1×FY 2024: 2.5×FY 2025: 1.9×
FY 2019 5y median 2.5× FY 2025
FCF Yield 4.0%
FY 2019: 0.0%FY 2020: -0.6%FY 2021: -2.7%FY 2022: -1.5%FY 2023: -2.0%FY 2024: 3.1%FY 2025: 4.0%
FY 2019 5y median -1.5% FY 2025

Profitability

Gross Margin 32.4%
FY 2019: 29.4%FY 2020: 35.6%FY 2021: 30.2%FY 2022: 27.6%FY 2023: 28.6%FY 2024: 32.2%FY 2025: 32.4%
FY 2019 5y median 30.2% FY 2025
Operating Margin 1.7%
FY 2019: 7.2%FY 2020: 4.1%FY 2021: -42.9%FY 2022: -24.5%FY 2023: -17.9%FY 2024: -2.5%FY 2025: 1.7%
FY 2019 5y median -17.9% FY 2025
Net Margin 0.7%
FY 2019: 2.7%FY 2020: -10.1%FY 2021: -46.0%FY 2022: -25.1%FY 2023: -17.6%FY 2024: -4.6%FY 2025: 0.7%
FY 2019 5y median -17.6% FY 2025
ROE 0.6%
FY 2019: -3.4%FY 2020: -3.8%FY 2021: -19.9%FY 2022: -14.2%FY 2023: -13.0%FY 2024: -4.0%FY 2025: 0.6%
FY 2019 5y median -13.0% FY 2025
ROIC 0.9%
FY 2019: 4.9%FY 2020: 0.9%FY 2021: -14.6%FY 2022: -9.5%FY 2023: -8.7%FY 2024: -1.6%FY 2025: 0.9%
FY 2019 5y median -8.7% FY 2025
ROA 0.4%
FY 2019: 2.0%FY 2020: -2.4%FY 2021: -15.9%FY 2022: -9.9%FY 2023: -8.8%FY 2024: -2.7%FY 2025: 0.4%
FY 2019 5y median -8.8% FY 2025

Growth (YoY)

Revenue 13.9%
FY 2019: 0.0%FY 2020: 77.5%FY 2021: 77.0%FY 2022: 28.8%FY 2023: 22.8%FY 2024: 18.5%FY 2025: 13.9%
FY 2019 FY 2025
Operating Income 176.4%
FY 2019: 0.0%FY 2020: 1.3%FY 2021: -1955.1%FY 2022: 26.6%FY 2023: 10.0%FY 2024: 83.3%FY 2025: 176.4%
FY 2019 FY 2025
EPS (diluted) 113.3%
FY 2019: 0.0%FY 2020: -418.7%FY 2021: -26.5%FY 2022: 41.9%FY 2023: 16.4%FY 2024: 70.6%FY 2025: 113.3%
FY 2019 FY 2025
Free Cash Flow 28.4%
FY 2019: 0.0%FY 2020: -1804.4%FY 2021: -82.6%FY 2022: 68.9%FY 2023: -116.9%FY 2024: 249.3%FY 2025: 28.4%
FY 2019 FY 2025

Financial Health

Current Ratio 1.7×
FY 2019: 0.5×FY 2020: 1.0×FY 2021: 2.3×FY 2022: 1.3×FY 2023: 1.1×FY 2024: 1.4×FY 2025: 1.7×
FY 2019 5y median 1.4× FY 2025
Quick Ratio 1.7×
FY 2019: 0.5×FY 2020: 1.0×FY 2021: 2.0×FY 2022: 1.3×FY 2023: 1.1×FY 2024: 1.4×FY 2025: 1.7×
FY 2019 5y median 1.4× FY 2025
Debt / Equity 0.1×
FY 2019: -0.5×FY 2020: 0.4×FY 2021: 0.1×FY 2022: 0.3×FY 2023: 0.4×FY 2024: 0.3×FY 2025: 0.1×
FY 2019 5y median 0.3× FY 2025
Net Debt / EBITDA -0.7×
FY 2019: 3.9×FY 2020: 39.6×FY 2021: -0.0×FY 2022: -2.6×FY 2023: -4.1×FY 2024: 8.3×FY 2025: -0.7×
FY 2019 5y median -0.7× FY 2025
Interest Coverage 2.1×
FY 2019: 2.8×FY 2020: 0.7×FY 2021: -7.4×FY 2022: -10.5×FY 2023: -8.9×FY 2024: -1.2×FY 2025: 2.1×
FY 2019 5y median -7.4× FY 2025

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31